Fandom

VroniPlag Wiki

Shg/Fragment 053 01

< Shg

31.380Seiten in
diesem Wiki
Seite hinzufügen
Diskussion0 Teilen

Störung durch Adblocker erkannt!


Wikia ist eine gebührenfreie Seite, die sich durch Werbung finanziert. Benutzer, die Adblocker einsetzen, haben eine modifizierte Ansicht der Seite.

Wikia ist nicht verfügbar, wenn du weitere Modifikationen in dem Adblocker-Programm gemacht hast. Wenn du sie entfernst, dann wird die Seite ohne Probleme geladen.


Typus
BauernOpfer
Bearbeiter
SleepyHollow02
Gesichtet
No.png
Untersuchte Arbeit:
Seite: 53, Zeilen: 1 ff. (komplett)
Quelle: Gu et al 2009
Seite(n): 0, Zeilen: 0
Figure 8: In vivo testosterone-HSA expression in APC mice

Confocal laser scanning microscopic analysis of APCMin/+ colon tumor frozen sections stained with testosterone-HSA-FITC, showing specific FITC-related fluorescence at the cell membranes. Visualization of nuclei was evident by DRAQ5™ staining. Magnification, ×100.

4.3 mAR activation by testosterone-HSA was followed by extensive reduction of tumor incidence in vivo

Having a clear indication for mAR-expression, the 12-week tumor incidence of colon tumors generated in Balb/c mice was assessed by chemical carcinogenesis (see Experimental Procedures) in the presence or absence of continuous testosterone-HSA treatment. The animals used for these studies were divided in two groups comprising 5 and 7 animals. One group (7 animals) was treated subcutaneously (3 times/week, for 12 weeks) with 5mg/kg testosterone-HSA, whereas the other group (5 animals) remained untreated. The results (Figure 9, A) show that testosterone-HSA-treatment produced a clear and significant reduction of tumor incidence by 65%. The histological analysis of tumors by Tunel assay (Figure 9, B) confirmed that apoptotic cells were present in significant numbers predominantly at the tumors of animals treated with testosterone-HSA, while they were significantly less in the non-treated animals. These results collectively show that mAR is a functional target that may be used for the selective elimination of colon cancer cells in vivo.

A) Confocal laser scanning microscopic analysis of Caco2 cells (a-d) stained with testosterone-HSA-FITC, showing specific FITC related fluorescence at the cell membranes (a, b). No apparent membrane fluorescence was shown in control samples stained with HSA-FITC (c, d). Visualization of nuclei was evident by DRAQ5™ staining. Magnification, ×100. B) Confocal laser scanning microscopic analysis of IEC 06 cells (e-f) stained with testosterone-HSA-FITC, showing no apparent membrane fluorescence at the cell membrane. Visualization of nuclei was evident by DRAQ5™ staining.

Having a clear indication for mAR-expression, we assessed the 12-week tumor incidence of colon tumors generated in Balb/c mice by chemical carcinogenesis (see Materials and Methods) in the presence or absence of continuous testosterone- HSA treatment. The animals used for these studies were divided in two groups comprising of 5 and 7 animals respectively. One group (7 animals) was treated subcutaneously (3 times/week for 12 weeks) with 5 mg/kg testosterone- HSA, whereas the other group (5 animals) remained untreated. The results (Fig. 7C) show that testosterone- HSA treatment produced a clear and significant reduction of tumor incidence by 65%. The histological analysis of tumors by TUNEL assay confirmed that apoptotic cells were present in significant numbers predominantly in the tumors of animals treated with testosterone- HSA (Fig. 7D, middle panels), while they were significantly less either in the non-treated animals (Fig. 7D, right panels), or in healthy tissues of treated animals (Fig. 7D, left panels). These results collectively show that mAR is a functional and specific target that may be used for the selective elimination of colon cancer cells in vivo.

Anmerkungen
Sichter
(SleepyHollow02)

Auch bei Fandom

Zufälliges Wiki